• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Summit Corp PLC

+ Add to Watchlist

SMXXF:US

0.1400 USD 0.0050 3.45%

As of 20:10:00 ET on 07/01/2014.

Snapshot for Summit Corp PLC (SMXXF)

Open: 0.1400 Day's Range: 0.1400 - 0.1400 Volume: 25,000
Previous Close: 0.1450 52wk Range: 2.4975 - 4.0000 1-Yr Rtn: -

Stock Chart for SMXXF

No chart data available.
  • SMXXF:US 0.1400
  • 1D
  • 1M
  • 1Y
0.1450
Interactive SMXXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SMXXF

Current P/E Ratio (ttm) -
Estimated P/E(01/2015) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (01/2015) -0.2430
Est. PEG Ratio -
Market Cap (M USD) 114.97
Shares Outstanding (M) 41.06
30 Day Average Volume 42
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SMXXF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SMXXF

Summit Corporation plc is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.

Glyn O EdwardsChief Executive OfficerErik OstrowskiChief Financial Officer
More Company Profile & Key Executives for SMXXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil